Disappearance of angiotensin from the circulation of the dog. 1967

R L Hodge, and K K Ng, and J R Vane

UI MeSH Term Description Entries
D008102 Liver Circulation The circulation of BLOOD through the LIVER. Hepatic Circulation,Circulation, Liver,Circulation, Hepatic
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D012077 Renal Artery A branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters. Arteries, Renal,Artery, Renal,Renal Arteries
D001776 Blood Circulation Time Determination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points. Circulation Time, Blood,Time, Blood Circulation,Blood Circulation Times,Circulation Times, Blood,Times, Blood Circulation
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005263 Femoral Artery The main artery of the thigh, a continuation of the external iliac artery. Common Femoral Artery,Arteries, Common Femoral,Arteries, Femoral,Artery, Common Femoral,Artery, Femoral,Common Femoral Arteries,Femoral Arteries,Femoral Arteries, Common,Femoral Artery, Common
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R L Hodge, and K K Ng, and J R Vane
February 1951, The American journal of physiology,
R L Hodge, and K K Ng, and J R Vane
March 1978, British journal of pharmacology,
R L Hodge, and K K Ng, and J R Vane
August 1968, Nature,
R L Hodge, and K K Ng, and J R Vane
January 1980, Clinical science (London, England : 1979),
R L Hodge, and K K Ng, and J R Vane
January 1958, Comptes rendus des seances de la Societe de biologie et de ses filiales,
R L Hodge, and K K Ng, and J R Vane
April 1950, Science (New York, N.Y.),
R L Hodge, and K K Ng, and J R Vane
December 1979, Journal of applied physiology: respiratory, environmental and exercise physiology,
R L Hodge, and K K Ng, and J R Vane
April 1966, The Journal of physiology,
R L Hodge, and K K Ng, and J R Vane
August 1967, Nature,
R L Hodge, and K K Ng, and J R Vane
January 1977, Bibliotheca anatomica,
Copied contents to your clipboard!